Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer

Figure 1

Characterization of plasma exosomes. (a) TEM image showing enriched plasma exosomes in NSCLC patients (scale bar, 100 nm). (b) The size distribution of exosomes was calculated by NanoSight. (c) CD63 and Hsp70 levels in purified plasma exosomes from NSCLC patients were detected by Western blotting.

(a)

(b)

(c)